Orna Therapeutics fetches $80m Series A

Orna Therapeutics, a biotechnology company, has raised $80 million in Series A financing.

Orna Therapeutics, a biotechnology company, has raised $80 million in Series A financing. MPM Capital, Taiho Ventures, and F2 Ventures led the round.

Source: Press Release